Veliparib, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery and Liver or Kidney Dysfunction
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Genmab
AstraZeneca
Eli Lilly and Company
Avenzo Therapeutics, Inc.
Deciphera Pharmaceuticals, LLC
Eli Lilly and Company
Sun Yat-sen University
OHSU Knight Cancer Institute
Emory University
Syros Pharmaceuticals
AIDS Malignancy Consortium
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Oncology Institute of Southern Switzerland
The Netherlands Cancer Institute
University of Chicago
The University of Texas Health Science Center at San Antonio
AbbVie
City of Hope Medical Center
National Cancer Institute (NCI)
Amgen
Swedish Medical Center